期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

生长抑素受体SPECT/CT融合成像对甲状腺相关眼病的临床评价 被引量：1

Clinical evaluation of somatostatin-receptor SPECT/CT confluence imaging in thyroid associated ophthalmopathy
下载PDF
导出
摘要 目前普遍认为细胞免疫是甲状腺相关眼病（Thyroid ass-ciated ophthalmopathy,TAO）的主要发病机制,以炎症、水肿和继发的眼眶组织的纤维化为特征。在疾病进程中,活化的成纤维细胞分泌亲水的葡萄糖胺聚精导敛局部水肿跟外肌和眼眶连接组织淋巴细胞的浸润，特别是T淋巴细胞和巨噬细胞，引起炎症。
作者 郑泓明 陈英敏 方凤宁
机构地区 河北医科大学第二医院核医学科 河北省人民医院医学影像科
出处 《中国临床医学影像杂志》 CAS 北大核心 2009年第6期464-466,共3页 Journal of China Clinic Medical Imaging
基金 河北省卫生厅青年指导计划课题(项目编号:06173)
关键词 格雷夫斯病 体层摄影术 发射型计算机 单光子
分类号 R771.3 [医药卫生—眼科] R817.4 [医药卫生—影像医学与核医学]
  • 相关文献

参考文献10

  • 1Wiersinga WM,Gerding MN,Pummel MF,et al.Octreotide scintigraphy in thyroidal and orbital Graves* disease[J].Thyroid,1998,8(5):433-436.
  • 2Gerding MN,Van der Zant FM,Van Royen EA,et al.Octreotide-scintigraphy is a disease activity parameter in Graves'ophthalmopathy[J].Clin Endocrinol,1999,50(3):373-379.
  • 3Sreedharan SP,Kodama KT,Peterson KE,et al.Distinct subsets of somatostatin receptors on cultured human lymphocytes[J].J Biol Chem,1989,264(2):949-952.
  • 4Daniela P,Antonio N,Giulio B,et al.Somatostatin receptor genes are expressed in lymphocytes from retroorbital tissues in Graves' disease[J].J Clin Endocrinol Metab,2002,87(11):5125-5129.
  • 5Kahaly G,Diaz M,Just M,et al.Role of octreoscan and correlation with MR imaging in Graves' ophthalmopathy[J].Thyroid,1995,5(2):107-111.
  • 6Annamaria C,Secondo L,Diego F,et al.Orbital scintigraphy with[^111In-Diethylenetriamine Pentancetic Acid-D-Phe1]-Octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy[J].J Clin Endocrinol Metab,1998,83(11):3790-3794.
  • 7Burggasser G,Hurtl I,Hauff W,et al.Orbital scintigraphy with the somatestatin receptor tracer ^99mTc-P829 in patients with Graves' disease[J].J Nucl Med,2003,44(10):1547-1555.
  • 8段炼,李险峰,陆克义,张承刚,胡光,刘建中,李思进.^(99)Tc^m-奥曲肽眼眶显像在甲状腺相关眼病中的临床应用[J].中华眼科杂志,2006(12):1068-1072. 被引量：18
  • 9Bartalena L,Marcocci C,Bogazzi F,et al.Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy[J].N Engl J Med,1998,338(2):73-78.
  • 10赵荣,汪静,邓敬兰,王江.^(99m)Tc直接法标记Octreotide及其在甲状腺突眼患者的临床初步应用研究[J].中国临床医学影像杂志,2007,18(8):533-536. 被引量：2

二级参考文献12

  • 1李玲,叶万忠,李建,陈侃,张春华,包建东.Graves眼病眶部生长抑素受体显像研究[J].中华核医学杂志,2005,25(3):166-167. 被引量：5
  • 2段炼,李险峰,胡光,张承刚,李思进.^(99)Tc^m-奥曲肽眼眶显像在甲状腺相关眼病中的初步应用[J].山西医科大学学报,2005,36(3):369-371. 被引量：1
  • 3管昌田.生长激素抑素肿瘤受体显像[J].国外医学[核医学放射医学分册],1994,18:24-27.
  • 4Bahn RS,Heufelder AE.Pathogenesis of Graves' ophthalmopathy[J].N Engl J Med,1993,329:1468-1475.
  • 5Kolan H,Li J,Thakur Ml.Sandostatin labeled with ^99mTc:in vitro stability,in vivo validity and comparison with 111In-DTPA-Octreotide[J].Peptide Res,1996,9:144-150.
  • 6Marcocci C,Marino M,Rocchi R.Novel aspects of immunosuppressive and radiotherapy management of Graves' ophthalmopathy[J].J Endocrinol Invest,2004,27:272-280.
  • 7Pervez S,Mushtaq A,Arif M.Technetium-99m direct radiolabeling of lanreotide:a somatostatin analog[J].Applied Radiation and Isotopes,2001,55(5):647-651.
  • 8Pearson DA,James JL,McBride WJ,et al.Somatostatin receptorbinding peptides labeled with ^99mTc:chemistry and initial biological studies[J].J Med Chem,1996,39:1361-1371.
  • 9Rodes BA.Direct labeling of proteins with Tc-99m[J].Nucl Med Biol,2001,18:667-676.
  • 10Paik CH,Phan L,Hong JJ,et al.The labeling of high affinity sites of antibodies with ^99mTc[J].Int J Nucl Med Biol,1985,12:3-8.

共引文献18

同被引文献31

  • 1段炼,李险峰,陆克义,张承刚,胡光,刘建中,李思进.^(99)Tc^m-奥曲肽眼眶显像在甲状腺相关眼病中的临床应用[J].中华眼科杂志,2006(12):1068-1072. 被引量：18
  • 2王筱璟.奥曲肽甲状腺内注射治疗甲状腺功能亢进症眼病32例临床分析[J].中原医刊,2004,31(14):37-37. 被引量：2
  • 3Brazeau P. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone[J].SCIENCE,1993,(68):77-79.
  • 4Vanetti M,Vogt G,Holh V. The tow isoforms of the mouse somatostatin receptor (mSSTR2A and mSSTR2B) differ in coupling efficiency to adenylate cyclase and in agonist-induced receptor desensitization[J].FEBS Letters,1993,(03):260-266.
  • 5Jenkins SA,Baxter JN,Ellenbogen S. Randomised trial of octreotide for long term management of cirrhosis after variceal haemorrhage[J].BMJ:British Medical Journal,1997,(7119):1338-1341.
  • 6Guillermet Guibert J,Lahlou H,Cordelier P. Physiology of somatostatin receptors[J].Endocrinol Invest,2005,(11):5-9.
  • 7Patel YC. Somatostatin and its receptor family[J].Front Neuroen-docrinol,1999.157-198.
  • 8Atkinson H,England JA,Rafferty A. Somatostatin receptor expression in thyroid disease[J].International Journal of Experimental Pathology,2013,(03):226-229.
  • 9Klagge A,Krause K,Schierle K. Somatostatin receptor subtype expression in human thyroid tumours[J].HORMONE AND METABOLIC RESEARCH,2010.237-240.
  • 10Aguirre-Balsalobre F,Mengual-Verdú E,Mu(n)oz-Acosta JM. Octreotide scintigraphy in thyroid orbitopathy[J].Arch Soc Esp Oftalmol,2007,(03):133-139.

引证文献1

二级引证文献1

中国临床医学影像杂志
2009年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部